Atika Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Atika Capital Management's ROIV Position: Q3 2026 in Review
Atika Capital Management increased its Roivant Sciences (ROIV) stake by 3.7% in Q3 2026, buying an estimated $290K and bringing the position to 225,000 shares worth $8.23M. The position accounts for 0.67% of the portfolio, ranked #42.
Atika Capital Management first reported a position in ROIV in Q4 2022 and has held it in 9 quarters since. The position peaked at $8.31M in Q4 2023. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Atika Capital Management held 225,000 shares of Roivant Sciences worth $8.23M as of Q3 2026.
- Atika Capital Management bought 8,000 Roivant Sciences shares in Q3 2026, an estimated $290K.
- Roivant Sciences made up 0.67% of Atika Capital Management's portfolio in Q3 2026, its #42 holding.
- Atika Capital Management first reported a position in Roivant Sciences in Q4 2022 and has held it in 9 quarters since.
- Atika Capital Management's Roivant Sciences position peaked at $8.31M in Q4 2023.
- 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Atika Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.